Winfried März

Synlab Czech (Czechia) — Czech Republic

Medicine · Health Sciences

126h-index145.7kcitations3.1kworks35.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(356), Diabetes, Cardiovascular Risks, and Lipoproteins(195), Genetic Associations and Epidemiology(117), Vitamin D Research Studies(106), Cancer, Lipids, and Metabolism(97)

Publications2.2k total

Non-linear association of coagulation factor XI with mortality
Med·2025· 1 citedOpen Access
Serum Amyloid A (SAA) and Its Interaction with High-Density Lipoprotein Cholesterol (HDL-C): A Comprehensive Review
International Journal of Molecular Sciences·2025Open Access
Reply to the Letter to the Editor: “Anti-inflammatory role of lipoprotein apheresis in the era of small interfering RNA inhibitor of apolipopritein(a)”
Clinical Research in Cardiology·2025Open Access
Predictive Performance of the Cardiovascular Event Risk Test 2 Risk Score in Hemodialysis Patients with ESKD
Clinical Journal of the American Society of Nephrology·2025Open Access
Loci for insulin processing and secretion provide insight into type 2 diabetes risk
UNC Libraries·2025Open Access
Cardiovascular risk assessment enhanced by automated machine learning in a multi-phase study
Scientific Reports·2025Open Access
Interpretable type 2 diabetes incidence prediction with AutoScore: A model based on standard clinical parameters
International Journal of Medical Informatics·2025
DNA Methylation Signatures of Alcohol Use Disorder – A large-scale Meta-Analysis in the Psychiatric Genomics Consortium
2025Open Access
Comparing Inflammatory Biomarkers in Cardiovascular Disease: Insights from the LURIC Study
International Journal of Molecular Sciences·2025· 4 citedOpen Access
438-P: Adipose-Tissue Insulin Resistance Predicts Mortality in Persons at Risk for Cardiac Diseases
Diabetes·2025
Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets
Cardiovascular Research·2025· 6 citedOpen Access
A multiomics approach reveals novel regulators of plasma factor V levels, highlighting CLEC4M as a clearance receptor
Blood·2025· 3 cited
A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels
UNC Libraries·2025Open Access
Die Insulinresistenz des Fettgewebes sagt die Mortalität bei Personen mit Risiko für Herzerkrankungen voraus
Diabetologie und Stoffwechsel·2025
Self-rated physical fitness predicts cardiovascular and all-cause mortality—implications for clinical decision-making
European Journal of Preventive Cardiology·2025Open Access
Statins for primary prevention of cardiovascular disease in Germany: benefits and costs
Clinical Research in Cardiology·2025· 1 citedOpen Access
Reduction of cardiovascular risk factors by the diet – Evaluation of the MoKaRi concept by a parallel-designed randomized study
Lipids in Health and Disease·2025· 2 citedOpen Access
Genome-wide association study meta-analysis provides insights into the etiology of heart failure and its subtypes
Nature Genetics·2025· 25 citedOpen Access
Lipid Dysregulation in Tangier Disease: A Case Series and Metabolic Characterization
The Journal of Clinical Endocrinology & Metabolism·2025· 3 citedOpen Access
Evaluation of current indirect methods for measuring LDL-cholesterol
Clinical Chemistry and Laboratory Medicine (CCLM)·2025· 4 cited
page 1 of 113Next →

Frequent Co-authors

Stefan Pilz(15), Marcus E. Kleber(12), Heribert Schunkert(9), Ulrich Laufs(7), Jeanette Erdmann(7), Bernhard O. Boehm(7), Børge G. Nordestgaard(6), Éric Bruckert(6), Ruth McPherson(6), Muredach P. Reilly(6), Eberhard Ritz(5), Frederick J. Raal(5), Raúl D. Santos(5), G. Kees Hovingh(5), M. John Chapman(5), Terho Lehtimäki(5), Themistocles L. Assimes(5), Nilesh J. Samani(5), Reijo Laaksonen(5), Andreas Tomaschitz(5)